Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

School level of children carrying a HNF1B variant or a deletion.

Laliève F, Decramer S, Heidet L, Baudouin V, Lahoche A, Llanas B, Cochat P, Tenenbaum J, Lavocat MP, Eckart P, Broux F, Roussey G, Cloarec S, Vrillon I, Dunand O, Bessenay L, Tsimaratos M, Nobili F, Pietrement C, De Parscau L, Bonneville V, Rodier N, Saint-Martin C, Chassaing N, Michel-Calemard L, Moriniere V, Bellanné-Chantelot C, Bahans C, Guigonis V.

Eur J Hum Genet. 2019 Sep 3. doi: 10.1038/s41431-019-0490-6. [Epub ahead of print]

PMID:
31481685
2.

Acute tubulointerstitial nephritis in children and chronic kidney disease.

Clavé S, Rousset-Rouvière C, Daniel L, Tsimaratos M.

Arch Pediatr. 2019 Jul;26(5):290-294. doi: 10.1016/j.arcped.2019.05.002. Epub 2019 Jul 4.

PMID:
31281039
3.

Quality of life in adolescents with chronic kidney disease who initiate haemodialysis treatment.

Clavé S, Tsimaratos M, Boucekine M, Ranchin B, Salomon R, Dunand O, Garnier A, Lahoche A, Fila M, Roussey G, Broux F, Harambat J, Cloarec S, Menouer S, Deschenes G, Vrillon I, Auquier P, Berbis J.

BMC Nephrol. 2019 May 14;20(1):163. doi: 10.1186/s12882-019-1365-3.

4.

Human papillomavirus type 7-associated anal condyloma after renal transplantation in a child.

Garaix F, Hery G, Tsimaratos M, Colson P, Tamalet C.

Pediatr Transplant. 2019 Aug;23(5):e13470. doi: 10.1111/petr.13470. Epub 2019 May 12.

PMID:
31081227
5.

Adverse events associated with currently used medical treatments for cystinuria and treatment goals: results from a series of 442 patients in France.

Prot-Bertoye C, Lebbah S, Daudon M, Tostivint I, Jais JP, Lillo-Le Louët A, Pontoizeau C, Cochat P, Bataille P, Bridoux F, Brignon P, Choquenet C, Combe C, Conort P, Decramer S, Doré B, Dussol B, Essig M, Frimat M, Gaunez N, Joly D, Le Toquin-Bernard S, Méjean A, Meria P, Morin D, N'Guyen HV, Normand M, Pietak M, Ronco P, Saussine C, Tsimaratos M, Friedlander G, Traxer O, Knebelmann B, Courbebaisse M; French Cystinuria Group.

BJU Int. 2019 Feb 24. doi: 10.1111/bju.14721. [Epub ahead of print]

PMID:
30801923
6.

Human Bacterial Repertoire of the Urinary Tract: a Potential Paradigm Shift.

Morand A, Cornu F, Dufour JC, Tsimaratos M, Lagier JC, Raoult D.

J Clin Microbiol. 2019 Feb 27;57(3). pii: e00675-18. doi: 10.1128/JCM.00675-18. Print 2019 Mar. Review.

7.

Patient and transplant outcome in infants starting renal replacement therapy before 2 years of age.

Hogan J, Bacchetta J, Charbit M, Roussey G, Novo R, Tsimaratos M, Terzic J, Ulinski T, Garnier A, Merieau E, Harambat J, Vrillon I, Dunand O, Morin D, Berard E, Nobili F, Couchoud C, Macher MA; French Pediatric Nephrology Society.

Nephrol Dial Transplant. 2018 Aug 1;33(8):1459-1465. doi: 10.1093/ndt/gfy040.

PMID:
29617835
8.

Rapid differential diagnosis of diabetes insipidus in a 7-month-old infant: The copeptin approach.

Vergier J, Fromonot J, Alvares De Azevedo Macedo A, Godefroy A, Marquant E, Guieu R, Tsimaratos M, Reynaud R.

Arch Pediatr. 2018 Jan;25(1):45-47. doi: 10.1016/j.arcped.2017.11.010. Epub 2017 Dec 11.

PMID:
29241593
9.

Differential diagnosis of thrombotic microangiopathy in nephrology.

Sakari Jokiranta T, Viklicky O, Al Shorafa S, Coppo R, Gasteyger C, Macia M, Pankratenko T, Shenoy M, Soylemezoglu O, Tsimaratos M, Wetzels J, Haller H.

BMC Nephrol. 2017 Oct 28;18(1):324. doi: 10.1186/s12882-017-0727-y.

10.

Clinical and genetic heterogeneity in familial steroid-sensitive nephrotic syndrome.

Dorval G, Gribouval O, Martinez-Barquero V, Machuca E, Tête MJ, Baudouin V, Benoit S, Chabchoub I, Champion G, Chauveau D, Chehade H, Chouchane C, Cloarec S, Cochat P, Dahan K, Dantal J, Delmas Y, Deschênes G, Dolhem P, Durand D, Ekinci Z, El Karoui K, Fischbach M, Grunfeld JP, Guigonis V, Hachicha M, Hogan J, Hourmant M, Hummel A, Kamar N, Krummel T, Lacombe D, Llanas B, Mesnard L, Mohsin N, Niaudet P, Nivet H, Parvex P, Pietrement C, de Pontual L, Noble CP, Ribes D, Ronco P, Rondeau E, Sallee M, Tsimaratos M, Ulinski T, Salomon R, Antignac C, Boyer O.

Pediatr Nephrol. 2018 Mar;33(3):473-483. doi: 10.1007/s00467-017-3819-9. Epub 2017 Oct 23.

PMID:
29058154
11.

Trends in the number and the quality of trial protocols involving children submitted to a French Institutional Review Board.

Gautier I, Janiaud P, Rollet N, André N, Tsimaratos M, Cornu C, Malik S, Gentile S, Kassaï B.

BMC Med Res Methodol. 2017 Aug 23;17(1):130. doi: 10.1186/s12874-017-0395-4.

12.

First isolation of Akkermansia muciniphila in a blood-culture sample.

Dubourg G, Cornu F, Edouard S, Battaini A, Tsimaratos M, Raoult D.

Clin Microbiol Infect. 2017 Sep;23(9):682-683. doi: 10.1016/j.cmi.2017.02.031. Epub 2017 Mar 6. No abstract available.

13.

Impact of a pharmacist-led medication review on hospital readmission in a pediatric and elderly population: study protocol for a randomized open-label controlled trial.

Renaudin P, Baumstarck K, Daumas A, Esteve MA, Gayet S, Auquier P, Tsimaratos M, Villani P, Honore S.

Trials. 2017 Feb 9;18(1):65. doi: 10.1186/s13063-017-1798-6.

14.
15.

'Urinacoccus massiliensis' gen. nov. sp. nov., identified in urine sample of a 7-year-old boy hospitalized for dental care under general anaesthesia.

Morand A, Cornu F, Tsimaratos M, Cadoret F, Lagier JC, Fournier PE, Raoult D.

New Microbes New Infect. 2016 Aug 4;14:36-7. doi: 10.1016/j.nmni.2016.07.017. eCollection 2016 Nov.

16.

Anaerococcus urinomassiliensis sp. nov., isolated from a urine sample of a 17-year-old boy affected by autoimmune hepatitis and membranoproliferative glomerulonephritis.

Morand A, Cornu F, Tsimaratos M, Lagier JC, Cadoret F, Fournier PE, Raoult D.

New Microbes New Infect. 2016 Jun 6;13:56-8. doi: 10.1016/j.nmni.2016.06.001. eCollection 2016 Sep.

17.

Actinomyces urinae sp. nov., isolated from 13-year-old girl affected by nephritic syndrome.

Morand A, Cornu F, Tsimaratos M, Lagier JC, Khelaifia S, Raoult D.

New Microbes New Infect. 2016 May 26;13:1-2. doi: 10.1016/j.nmni.2016.05.013. eCollection 2016 Sep.

18.

[Going on rounds: Reintroducing humanity in medical care].

Tsimaratos M, Sarles J.

Arch Pediatr. 2016 Apr;23(4):323-4. doi: 10.1016/j.arcped.2016.01.012. Epub 2016 Feb 24. French. No abstract available.

PMID:
26922569
19.

Lack of IL7Rα expression in T cells is a hallmark of T-cell immunodeficiency in Schimke immuno-osseous dysplasia (SIOD).

Sanyal M, Morimoto M, Baradaran-Heravi A, Choi K, Kambham N, Jensen K, Dutt S, Dionis-Petersen KY, Liu LX, Felix K, Mayfield C, Dekel B, Bokenkamp A, Fryssira H, Guillen-Navarro E, Lama G, Brugnara M, Lücke T, Olney AH, Hunley TE, Polat AI, Yis U, Bogdanovic R, Mitrovic K, Berry S, Najera L, Najafian B, Gentile M, Nur Semerci C, Tsimaratos M, Lewis DB, Boerkoel CF.

Clin Immunol. 2015 Dec;161(2):355-65. doi: 10.1016/j.clim.2015.10.005. Epub 2015 Oct 21.

PMID:
26499378
20.

CKD and Its Risk Factors among Patients with Cystinuria.

Prot-Bertoye C, Lebbah S, Daudon M, Tostivint I, Bataille P, Bridoux F, Brignon P, Choquenet C, Cochat P, Combe C, Conort P, Decramer S, Doré B, Dussol B, Essig M, Gaunez N, Joly D, Le Toquin-Bernard S, Méjean A, Meria P, Morin D, N'Guyen HV, Noël C, Normand M, Pietak M, Ronco P, Saussine C, Tsimaratos M, Friedlander G, Traxer O, Knebelmann B, Courbebaisse M; French Cystinuria Group.

Clin J Am Soc Nephrol. 2015 May 7;10(5):842-51. doi: 10.2215/CJN.06680714. Epub 2015 Feb 25.

21.

Loss-of-function mutations in WDR73 are responsible for microcephaly and steroid-resistant nephrotic syndrome: Galloway-Mowat syndrome.

Colin E, Huynh Cong E, Mollet G, Guichet A, Gribouval O, Arrondel C, Boyer O, Daniel L, Gubler MC, Ekinci Z, Tsimaratos M, Chabrol B, Boddaert N, Verloes A, Chevrollier A, Gueguen N, Desquiret-Dumas V, Ferré M, Procaccio V, Richard L, Funalot B, Moncla A, Bonneau D, Antignac C.

Am J Hum Genet. 2014 Dec 4;95(6):637-48. doi: 10.1016/j.ajhg.2014.10.011. Epub 2014 Nov 13.

22.

Increased systemic blood pressure and arterial stiffness in young adults born prematurely.

Tauzin L, Rossi P, Grosse C, Boussuges A, Frances Y, Tsimaratos M, Simeoni U.

J Dev Orig Health Dis. 2014 Dec;5(6):448-52. doi: 10.1017/S2040174414000385. Epub 2014 Aug 26.

PMID:
25154472
23.

Rituximab fails where eculizumab restores renal function in C3nef-related DDD.

Rousset-Rouvière C, Cailliez M, Garaix F, Bruno D, Laurent D, Tsimaratos M.

Pediatr Nephrol. 2014 Jun;29(6):1107-11. doi: 10.1007/s00467-013-2711-5. Epub 2014 Jan 10.

PMID:
24408225
24.

Recruitment in pediatric clinical research was influenced by study characteristics and pediatricians' perceptions: a multicenter survey.

Kaguelidou F, Amiel P, Blachier A, Iliescu C, Rozé JC, Tsimaratos M, Brandt C, Kassai-Koupai B, Jacqz-Aigrain E, Gaultier C, Alberti C.

J Clin Epidemiol. 2013 Oct;66(10):1151-7. doi: 10.1016/j.jclinepi.2013.04.015. Epub 2013 Jul 12.

PMID:
23856188
25.

[Amanita proxima poisoning in a child].

Marquant E, Rousset-Rouvière C, Bosdure E, de Haro L, Paut O, Tsimaratos M, Dubus JC.

Arch Pediatr. 2011 Dec;18(12):1290-3. doi: 10.1016/j.arcped.2011.08.029. Epub 2011 Oct 7. French.

PMID:
21982976
26.

[Enzyme therapy in Fabry disease: when scarcity of one enzyme illustrates the vulnerability of biotech].

Lidove O, Choukroun G, Bekri S, Viot G, Tsimaratos M, Joly D.

Presse Med. 2010 May;39(5):527-9. doi: 10.1016/j.lpm.2010.01.002. Epub 2010 Mar 2. French. No abstract available.

PMID:
20194001
27.

Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patients.

Zhao W, Fakhoury M, Deschênes G, Roussey G, Brochard K, Niaudet P, Tsimaratos M, André JL, Cloarec S, Cochat P, Bensman A, Azougagh S, Jacqz-Aigrain E.

J Clin Pharmacol. 2010 Nov;50(11):1280-91. doi: 10.1177/0091270009357429. Epub 2010 Feb 10.

PMID:
20147615
28.

Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome.

Harambat J, Fargue S, Acquaviva C, Gagnadoux MF, Janssen F, Liutkus A, Mourani C, Macher MA, Abramowicz D, Legendre C, Durrbach A, Tsimaratos M, Nivet H, Girardin E, Schott AM, Rolland MO, Cochat P.

Kidney Int. 2010 Mar;77(5):443-9. doi: 10.1038/ki.2009.435. Epub 2009 Dec 16.

29.

Early postnatal overfeeding induces early chronic renal dysfunction in adult male rats.

Boubred F, Daniel L, Buffat C, Feuerstein JM, Tsimaratos M, Oliver C, Dignat-George F, Lelièvre-Pégorier M, Simeoni U.

Am J Physiol Renal Physiol. 2009 Oct;297(4):F943-51. doi: 10.1152/ajprenal.90704.2008. Epub 2009 Aug 5.

30.

Effect of conservative treatment on the renal outcome of children with primary hyperoxaluria type 1.

Fargue S, Harambat J, Gagnadoux MF, Tsimaratos M, Janssen F, Llanas B, Berthélémé JP, Boudailliez B, Champion G, Guyot C, Macher MA, Nivet H, Ranchin B, Salomon R, Taque S, Rolland MO, Cochat P.

Kidney Int. 2009 Oct;76(7):767-73. doi: 10.1038/ki.2009.237. Epub 2009 Jul 1.

31.

[How to delay progression of chronic renal failure?].

Garaix F, Rousset Rouvière C, Cailliez M, Bruno D, Tsimaratos M.

Arch Pediatr. 2009 Jun;16(6):703-5. doi: 10.1016/S0929-693X(09)74119-3. French. No abstract available.

PMID:
19541137
32.

[Kidney and vaculitis in children].

Rousset-Rouvière C, Garaix F, Cailliez M, Bruno D, Coulibaly B, Daniel L, Tsimaratos M.

Arch Pediatr. 2009 Jun;16(6):529-31. doi: 10.1016/S0929-693X(09)74055-2. French. No abstract available.

PMID:
19541073
33.

Enteric-coated mycophenolate sodium in de novo pediatric renal transplant patients.

Niaudet P, Charbit M, Loirat C, Lapeyraque AL, Tsimaratos M, Cailliez M, Foulard M, Dehennault M, Marquet P, Chaouche-Teyara K, Lemay D.

Pediatr Nephrol. 2009 Feb;24(2):395-402. doi: 10.1007/s00467-008-1031-7. Epub 2008 Nov 5.

PMID:
18985393
34.

[What is the health insurance-Sécurité Sociale status for patients with Fabry disease?].

Lidove O, Choukroun G, Tsimaratos M, Jaussaud R; Conseil Scientifique de L'APMF (Association des Patients de la Maladie de Fabry).

Presse Med. 2008 Oct;37(10):1503-5. doi: 10.1016/j.lpm.2008.06.010. Epub 2008 Aug 30. French. No abstract available.

PMID:
18757167
35.

C-Peptide effects on renal physiology and diabetes.

Rebsomen L, Khammar A, Raccah D, Tsimaratos M.

Exp Diabetes Res. 2008;2008:281536. doi: 10.1155/2008/281536. Review.

36.

Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry disease.

Wraith JE, Tylki-Szymanska A, Guffon N, Lien YH, Tsimaratos M, Vellodi A, Germain DP.

J Pediatr. 2008 Apr;152(4):563-70, 570.e1. doi: 10.1016/j.jpeds.2007.09.007. Epub 2007 Dec 3.

PMID:
18346516
37.

[Mycophenolate mofetil restores renal function and spares steroids during idiopathic nephrotic syndrome in children. A cohort study].

Cailliez M, Bruno D, Daniel L, Afaneti M, Bérard E, Sarles J, Tsimaratos M.

Nephrol Ther. 2008 Feb;4(1):15-20. Epub 2007 Dec 21. French.

PMID:
18096455
38.

Effects of early postnatal hypernutrition on nephron number and long-term renal function and structure in rats.

Boubred F, Buffat C, Feuerstein JM, Daniel L, Tsimaratos M, Oliver C, Lelièvre-Pégorier M, Simeoni U.

Am J Physiol Renal Physiol. 2007 Dec;293(6):F1944-9. Epub 2007 Sep 26.

39.

Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.

Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, Boudailliez B, Bouissou F, Deschenes G, Gie S, Tsimaratos M, Fischbach M, Morin D, Nivet H, Alberti C, Loirat C; French Society of Pediatric Nephrology.

J Am Soc Nephrol. 2007 Aug;18(8):2392-400. Epub 2007 Jun 28.

40.

[Diabetes mellitus and renal tubule functions].

Rebsomen L, Raccah D, Tsimaratos M.

Nephrol Ther. 2006 Jan;2 Suppl 1:S28-31. Review. French.

PMID:
17378137
41.

[Fabry disease: proposed guidelines from a French expert group for its diagnosis, treatment and follow-up].

Lidove O, Bekri S, Goizet C, Khau Van Kien A, Aractingi S, Knebelmann B, Choukroun G, Tsimaratos M, Redonnet-Vernhet I, Lacombe D, Jaussaud R.

Presse Med. 2007 Jul-Aug;36(7-8):1084-97. Epub 2007 Feb 2. Review. French.

PMID:
17276649
42.

Darbepoetin, effective treatment of anaemia in paediatric patients with chronic renal failure.

André JL, Deschênes G, Boudailliez B, Broux F, Fischbach M, Gagnadoux MF, Horen B, Lahoche-Manucci A, Macher MA, Roussel B, Tsimaratos M, Loirat C.

Pediatr Nephrol. 2007 May;22(5):708-14. Epub 2007 Jan 11.

PMID:
17216497
43.

Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis.

Cailliez M, Garaix F, Rousset-Rouvière C, Bruno D, Kone-Paut I, Sarles J, Chabrol B, Tsimaratos M.

J Inherit Metab Dis. 2006 Dec;29(6):763. Epub 2006 Nov 10.

PMID:
17103011
44.

Schimke immunoosseous dysplasia: suggestions of genetic diversity.

Clewing JM, Fryssira H, Goodman D, Smithson SF, Sloan EA, Lou S, Huang Y, Choi K, Lücke T, Alpay H, André JL, Asakura Y, Biebuyck-Gouge N, Bogdanovic R, Bonneau D, Cancrini C, Cochat P, Cockfield S, Collard L, Cordeiro I, Cormier-Daire V, Cransberg K, Cutka K, Deschenes G, Ehrich JH, Fründ S, Georgaki H, Guillen-Navarro E, Hinkelmann B, Kanariou M, Kasap B, Kilic SS, Lama G, Lamfers P, Loirat C, Majore S, Milford D, Morin D, Ozdemir N, Pontz BF, Proesmans W, Psoni S, Reichenbach H, Reif S, Rusu C, Saraiva JM, Sakallioglu O, Schmidt B, Shoemaker L, Sigaudy S, Smith G, Sotsiou F, Stajic N, Stein A, Stray-Pedersen A, Taha D, Taque S, Tizard J, Tsimaratos M, Wong NA, Boerkoel CF.

Hum Mutat. 2007 Mar;28(3):273-83.

PMID:
17089404
45.

Crescentic glomerulonephritis is part of hyperimmunoglobulinemia D syndrome.

Cailliez M, Garaix F, Rousset-Rouvière C, Bruno D, Daniel L, Chabrol B, Sarles J, Tsimaratos M.

Pediatr Nephrol. 2006 Dec;21(12):1917-8. Epub 2006 Sep 1. No abstract available.

PMID:
16947033
46.

C-peptide replacement improves weight gain and renal function in diabetic rats.

Rebsomen L, Pitel S, Boubred F, Buffat C, Feuerstein JM, Raccah D, Vague P, Tsimaratos M.

Diabetes Metab. 2006 Jun;32(3):223-8.

PMID:
16799398
47.

Association of reduced red blood cell deformability and diabetic nephropathy.

Rebsomen L, Tsimaratos M.

Kidney Int. 2005 May;67(5):2066; author reply 2066-7. No abstract available.

48.

[Physiological effects of the connecting peptide].

Tsimaratos M.

Arch Pediatr. 2005 Apr;12(4):442-8. Review. French.

PMID:
15808437
49.

[Physiological effects of C-peptide].

Tsimaratos M.

Nephrologie. 2004;25(5):155-61. Review. French.

PMID:
15455788
50.

C-peptide, Na+,K(+)-ATPase, and diabetes.

Vague P, Coste TC, Jannot MF, Raccah D, Tsimaratos M.

Exp Diabesity Res. 2004 Jan-Mar;5(1):37-50. Review.

Supplemental Content

Loading ...
Support Center